Skip to content
OpenCapital
Get started

OrthoPediatrics KIDS Q1 2026 earnings

Reported April 30, 2026 · After market close

Revenue$59.4MBeat by $1.1M
EPS-$0.42Miss by $0.04
Revenue estimate$58.3M
EPS estimate-$0.38

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$68.2M
EPS estimate-$0.31

Financials

Q1 2026

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$509.08M-8.2%
Enterprise value$500.24M-1.8%
P/S2.1×-0.4×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0×0.0×
Current ratio5.2×-1.0×

Segments

By product

See full
Trauma and deformity$43.0M+13.7%
Scoliosis$15.4M+13.0%
Sports medicine/other$875.0K-0.6%

Versus estimates

Revenue

Q1 2026$59.4MBeat by $1.1M
Q4 2025$61.6MBeat by $1.4MQ3 2025$61.3MBeat by $2.0MQ2 2025$61.1MMiss by $317.6KQ1 2025$52.4MBeat by $728.1KQ4 2024$52.7MMiss by $317.0K

Diluted EPS

Q1 2026-$0.42Miss by $0.04
Q4 2025-$0.26Beat by $0.11Q3 2025-$0.24Beat by $0.02Q2 2025-$0.11Beat by $0.06Q1 2025-$0.39Miss by $0.13Q4 2024-$0.29Beat by $0.04

Ask the moment OrthoPediatrics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did OrthoPediatrics report Q1 2026 earnings?
OrthoPediatrics (KIDS) reported Q1 2026 earnings on April 30, 2026 after market close.
What were OrthoPediatrics's Q1 2026 revenue and EPS?
OrthoPediatrics reported revenue of $59.4M and eps of $-0.42 for Q1 2026.
Did OrthoPediatrics beat estimates in Q1 2026?
Revenue beat the consensus estimate of $58.3M by $1.1M. EPS missed the consensus estimate of $-0.38 by $0.04.
How did OrthoPediatrics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.3% from $52.4M a year earlier and eps declined 7.7% from $-0.39.
Where can I find OrthoPediatrics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001425450-26-000032) and the 10-Q periodic report (0001425450-26-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.